Renalytix Plc (AIM:RENX)
London · Delayed Price · Currency is GBP · Price in GBX 6.75
0.00 (0.00%)
At close: Dec 5, 2025
Renalytix Market Cap
Renalytix has a market cap or net worth of 29.5 million as of December 5, 2025. Its market cap has increased by 22.85% in one year.
Market Cap
29.50M
Enterprise Value
32.86M
Revenue
2.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.75
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 29.50M, a decrease of -54.32%. That is a compound annual growth rate of -10.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 29.50M | -17.15% |
| Dec 31, 2024 | 35.60M | 129.87% |
| Dec 29, 2023 | 15.49M | -71.47% |
| Dec 30, 2022 | 54.30M | -87.89% |
| Dec 31, 2021 | 448.32M | 27.67% |
| Dec 31, 2020 | 351.14M | 62.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.56B |
| GSK plc | 73.29B |
| Haleon | 32.02B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.45B |
| Hikma Pharmaceuticals | 3.52B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.77B |